Sirio Pharma Co.,Ltd.’s Net Profit Dropped 74.5% in First Quarter of 2022

Sirio Pharma Co.,Ltd. (仙乐健康科技股份有限公司) (300791.SZ) reported a net profit of 14.6 million yuan in the first quarter of 2022, down 74.5% year-on-year.

Meanwhile, the company posted 421.2 million yuan in revenue, down 17% year-on-year.

At the end of the reporting period, it had 3.9 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 33.4%.